Q3 2018 Indivior PLC Earnings Call
Conference Call Indivior PLC
Indivior PLC Conference call or earnings call will be held on Nov 1, 2018 via an 800 number (toll-free). During the earnings conference call's session Indivior PLC will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Indivior PLC for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. The Company's treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia. Indivior's products, which are sold in over 40 countries, consist of Suboxone film (buprenorphine and naloxone), Suboxone tablet (buprenorphine and naloxone) and Subutex tablet (buprenorphine sublingual tablet), all of which are used to treat opioid dependence. Its Buprenorphine lifecycle includes Suboxone Tablet, Suboxone Film, Buprenorphine Monthly Depot and Oral Swallowable Capsule. Its overdose rescue product category includes Cocaine Esterase. Its alcohol use disorders product category includes Arbaclofen Placarbil. Its adjacency-schizophrenia product category includes Risperidone Monthly Depot.Read more Conference Call